APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Solutions

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Selected research

Industry Growth & Trends

Global Intravenous Solutions Industry Growth and Trends Forecast to 2032

20 December 202591 pages

Choose your research edition.

Industry ResearchIntravenous Solutions Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Solutions Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Intravenous Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Solutions Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Solutions Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.

Read the full market overview

In terms of product, Crystalloids is the largest segment, with a share over 75%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.

Report Scope

This report provides a structured, data-driven view of the global Intravenous Solutions market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intravenous Solutions market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intravenous Solutions market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intravenous Solutions.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intravenous Solutions market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intravenous Solutions Market by Company

Baxter

Kelun Group

Fresenius Kabi

Otsuka

ICU Medical

Fresenius Kabi

JW Life Science

B. Braun Melsungen

Intravenous Solutions Segment by Type

Crystalloids

Colloids

Others

Intravenous Solutions Segment by Application

Basic IV Solutions

Nutrient Infusion Solution

Others

Intravenous Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous Solutions manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intravenous Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Crystalloids Table 2. Major Company of Colloids Table 3. Major Company of Others Table 4. Global Intravenous Solutions Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Intravenous Solutions Sales by Type (2021-2026) & (M Units) Table 6. Global Intravenous Solutions Sales Market Share in Volume by Type (2021-2026) Table 7. Global Intravenous Solutions Sales by Type (2021-2026) & (US$ Million) Table 8. Global Intravenous Solutions Sales Market Share in Value by Type (2021-2026) Table 9. Global Intravenous Solutions Price by Type (2021-2026) & (US$/K Unit) Table 10. Global Intravenous Solutions Sales by Type (2027-2032) & (M Units) Table 11. Global Intravenous Solutions Sales Market Share in Volume by Type (2027-2032) Table 12. Global Intravenous Solutions Sales by Type (2027-2032) & (US$ Million) Table 13. Global Intravenous Solutions Sales Market Share in Value by Type (2027-2032) Table 14. Global Intravenous Solutions Price by Type (2027-2032) & (US$/K Unit) Table 15. North America Intravenous Solutions Sales by Type (2021-2026) & (M Units) Table 16. North America Intravenous Solutions Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Intravenous Solutions Sales by Type (2021-2026) & (M Units) Table 18. Europe Intravenous Solutions Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Intravenous Solutions Sales by Type (2021-2026) & (M Units) Table 20. Asia-Pacific Intravenous Solutions Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Intravenous Solutions Sales by Type (2021-2026) & (M Units) Table 22. Latin America Intravenous Solutions Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Intravenous Solutions Sales by Type (2021-2026) & (M Units) Table 24. Middle East and Africa Intravenous Solutions Sales by Type (2021-2026) & (US$ Million) Table 25. Intravenous Solutions Industry Trends Table 26. Intravenous Solutions Industry Drivers Table 27. Intravenous Solutions Industry Opportunities and Challenges Table 28. Intravenous Solutions Industry Restraints Table 29. Global Intravenous Solutions Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Intravenous Solutions Revenue Market Share by Company (2021-2026) Table 31. Global Intravenous Solutions Sales by Company (2021-2026) & (M Units) Table 32. Global Intravenous Solutions Sales Share by Company (2021-2026) Table 33. Global Intravenous Solutions Market Price by Company (2021-2026) & (US$/K Unit) Table 34. Global Intravenous Solutions Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Intravenous Solutions Major Company Production Sites and Headquarters Table 36. Global Intravenous Solutions Company, Product Type & Application Table 37. Global Intravenous Solutions Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Intravenous Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Intravenous Solutions Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Intravenous Solutions Sales by Region (2021-2026) & (M Units) Table 42. Global Intravenous Solutions Sales Market Share in Volume by Region (2021-2026) Table 43. Global Intravenous Solutions Sales by Region (2021-2026) & (US$ Million) Table 44. Global Intravenous Solutions Sales Market Share in Value by Region (2021-2026) Table 45. Global Intravenous Solutions Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 46. Global Intravenous Solutions Sales by Region (2027-2032) & (M Units) Table 47. Global Intravenous Solutions Sales Market Share in Volume by Region (2027-2032) Table 48. Global Intravenous Solutions Sales by Region (2027-2032) & (US$ Million) Table 49. Global Intravenous Solutions Sales Market Share in Value by Region (2027-2032) Table 50. Global Intravenous Solutions Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2027-2032) Table 51. Global Intravenous Solutions Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Intravenous Solutions Sales by Application (2021-2026) & (M Units) Table 53. Global Intravenous Solutions Sales Market Share in Volume by Application (2021-2026) Table 54. Global Intravenous Solutions Sales by Application (2021-2026) & (US$ Million) Table 55. Global Intravenous Solutions Sales Market Share in Value by Application (2021-2026) Table 56. Global Intravenous Solutions Price by Application (2021-2026) & (US$/K Unit) Table 57. Global Intravenous Solutions Sales by Application (2027-2032) & (M Units) Table 58. Global Intravenous Solutions Sales Market Share in Volume by Application (2027-2032) Table 59. Global Intravenous Solutions Sales by Application (2027-2032) & (US$ Million) Table 60. Global Intravenous Solutions Sales Market Share in Value by Application (2027-2032) Table 61. Global Intravenous Solutions Price by Application (2027-2032) & (US$/K Unit) Table 62. North America Intravenous Solutions Sales by Application (2021-2026) & (M Units) Table 63. North America Intravenous Solutions Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Intravenous Solutions Sales by Application (2021-2026) & (M Units) Table 65. Europe Intravenous Solutions Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Intravenous Solutions Sales by Application (2021-2026) & (M Units) Table 67. Asia-Pacific Intravenous Solutions Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Intravenous Solutions Sales by Application (2021-2026) & (M Units) Table 69. Latin America Intravenous Solutions Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Intravenous Solutions Sales by Application (2021-2026) & (M Units) Table 71. Middle East and Africa Intravenous Solutions Sales by Application (2021-2026) & (US$ Million) Table 72. Baxter Company Information Table 73. Baxter Business Overview Table 74. Baxter Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 75. Baxter Intravenous Solutions Product Portfolio Table 76. Baxter Recent Development Table 77. Kelun Group Company Information Table 78. Kelun Group Business Overview Table 79. Kelun Group Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 80. Kelun Group Intravenous Solutions Product Portfolio Table 81. Kelun Group Recent Development Table 82. Fresenius Kabi Company Information Table 83. Fresenius Kabi Business Overview Table 84. Fresenius Kabi Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 85. Fresenius Kabi Intravenous Solutions Product Portfolio Table 86. Fresenius Kabi Recent Development Table 87. Otsuka Company Information Table 88. Otsuka Business Overview Table 89. Otsuka Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 90. Otsuka Intravenous Solutions Product Portfolio Table 91. Otsuka Recent Development Table 92. ICU Medical Company Information Table 93. ICU Medical Business Overview Table 94. ICU Medical Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 95. ICU Medical Intravenous Solutions Product Portfolio Table 96. ICU Medical Recent Development Table 97. Fresenius Kabi Company Information Table 98. Fresenius Kabi Business Overview Table 99. Fresenius Kabi Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 100. Fresenius Kabi Intravenous Solutions Product Portfolio Table 101. Fresenius Kabi Recent Development Table 102. JW Life Science Company Information Table 103. JW Life Science Business Overview Table 104. JW Life Science Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 105. JW Life Science Intravenous Solutions Product Portfolio Table 106. JW Life Science Recent Development Table 107. B. Braun Melsungen Company Information Table 108. B. Braun Melsungen Business Overview Table 109. B. Braun Melsungen Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 110. B. Braun Melsungen Intravenous Solutions Product Portfolio Table 111. B. Braun Melsungen Recent Development Table 112. North America Intravenous Solutions Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 113. North America Intravenous Solutions Sales by Country (2021-2026) & (M Units) Table 114. North America Intravenous Solutions Sales Market Share by Country (2021-2026) Table 115. North America Intravenous Solutions Sales Forecast by Country (2027-2032) & (M Units) Table 116. North America Intravenous Solutions Sales Market Share Forecast by Country (2027-2032) Table 117. North America Intravenous Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Intravenous Solutions Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Intravenous Solutions Market Share by Country (2021-2026) Table 120. North America Intravenous Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Intravenous Solutions Market Share Forecast by Country (2027-2032) Table 122. Europe Intravenous Solutions Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 123. Europe Intravenous Solutions Sales by Country (2021-2026) & (M Units) Table 124. Europe Intravenous Solutions Sales Market Share by Country (2021-2026) Table 125. Europe Intravenous Solutions Sales Forecast by Country (2027-2032) & (M Units) Table 126. Europe Intravenous Solutions Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Intravenous Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Intravenous Solutions Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Intravenous Solutions Market Share by Country (2021-2026) Table 130. Europe Intravenous Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Intravenous Solutions Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Intravenous Solutions Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Intravenous Solutions Sales by Country (2021-2026) & (M Units) Table 134. Asia-Pacific Intravenous Solutions Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Intravenous Solutions Sales Forecast by Country (2027-2032) & (M Units) Table 136. Asia-Pacific Intravenous Solutions Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Intravenous Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Intravenous Solutions Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Intravenous Solutions Market Share by Country (2021-2026) Table 140. Asia-Pacific Intravenous Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Intravenous Solutions Market Share Forecast by Country (2027-2032) Table 142. Latin America Intravenous Solutions Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 143. Latin America Intravenous Solutions Sales by Country (2021-2026) & (M Units) Table 144. Latin America Intravenous Solutions Sales Market Share by Country (2021-2026) Table 145. Latin America Intravenous Solutions Sales Forecast by Country (2027-2032) & (M Units) Table 146. Latin America Intravenous Solutions Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Intravenous Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Intravenous Solutions Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Intravenous Solutions Market Share by Country (2021-2026) Table 150. Latin America Intravenous Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Intravenous Solutions Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Intravenous Solutions Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Intravenous Solutions Sales by Country (2021-2026) & (M Units) Table 154. Middle East and Africa Intravenous Solutions Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Intravenous Solutions Sales Forecast by Country (2027-2032) & (M Units) Table 156. Middle East and Africa Intravenous Solutions Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Intravenous Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Intravenous Solutions Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Intravenous Solutions Market Share by Country (2021-2026) Table 160. Middle East and Africa Intravenous Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Intravenous Solutions Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Intravenous Solutions Distributors List Table 165. Intravenous Solutions Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Intravenous Solutions Image Figure 2. Global Intravenous Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Solutions Sales (2021-2032) & (M Units) Figure 5. Crystalloids Image Figure 6. Global Crystalloids Sales YoY Growth (2021-2032) & (M Units) Figure 7. Colloids Image Figure 8. Global Colloids Sales YoY Growth (2021-2032) & (M Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 11. Global Intravenous Solutions Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Intravenous Solutions Market Share by Type 2025 VS 2032 Figure 13. North America Intravenous Solutions Sales Market Share in Volume by Type in 2025 Figure 14. North America Intravenous Solutions Sales Market Share in Value by Type in 2025 Figure 15. Europe Intravenous Solutions Sales Market Share in Volume by Type in 2025 Figure 16. Europe Intravenous Solutions Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Intravenous Solutions Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Intravenous Solutions Sales Market Share in Value by Type in 2025 Figure 19. Latin America Intravenous Solutions Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Intravenous Solutions Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Intravenous Solutions Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Intravenous Solutions Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Intravenous Solutions Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Basic IV Solutions Image Figure 26. Global Basic IV Solutions Sales YoY Growth (2021-2032) & (M Units) Figure 27. Nutrient Infusion Solution Image Figure 28. Global Nutrient Infusion Solution Sales YoY Growth (2021-2032) & (M Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 31. Global Intravenous Solutions Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Intravenous Solutions Market Share by Application 2025 VS 2032 Figure 33. North America Intravenous Solutions Sales Market Share in Volume by Application in 2025 Figure 34. North America Intravenous Solutions Sales Market Share in Value by Application in 2025 Figure 35. Europe Intravenous Solutions Sales Market Share in Volume by Application in 2025 Figure 36. Europe Intravenous Solutions Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Intravenous Solutions Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Intravenous Solutions Sales Market Share in Value by Application in 2025 Figure 39. Latin America Intravenous Solutions Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Intravenous Solutions Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Intravenous Solutions Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Intravenous Solutions Sales Market Share in Value by Application in 2025 Figure 43. North America Intravenous Solutions Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 44. North America Intravenous Solutions Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Intravenous Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Intravenous Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Intravenous Solutions Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 48. Europe Intravenous Solutions Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Intravenous Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Intravenous Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Intravenous Solutions Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 52. Asia-Pacific Intravenous Solutions Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Intravenous Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Intravenous Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Intravenous Solutions Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 56. Latin America Intravenous Solutions Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Intravenous Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Intravenous Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Intravenous Solutions Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 60. Middle East and Africa Intravenous Solutions Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Intravenous Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Intravenous Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Intravenous Solutions Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Intravenous Solutions Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Crystalloids
  • Colloids
  • Others
Applications
  • Basic IV Solutions
  • Nutrient Infusion Solution
  • Others
Companies covered
  • Baxter
  • Kelun Group
  • Fresenius Kabi
  • Otsuka
  • ICU Medical
  • Fresenius Kabi
  • JW Life Science
  • B. Braun Melsungen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Solutions Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intravenous Solutions Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intravenous Solutions Market by Type
  6. 1.3.1 Crystalloids
  7. 1.3.2 Colloids
  8. 1.3.3 Others
  9. 1.4 Global Intravenous Solutions Market Size by Type
  10. 1.4.1 Global Intravenous Solutions Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Intravenous Solutions Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Intravenous Solutions Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Intravenous Solutions Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Intravenous Solutions Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Intravenous Solutions Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Intravenous Solutions Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Intravenous Solutions Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intravenous Solutions Industry Trends
  2. 2.2 Intravenous Solutions Industry Drivers
  3. 2.3 Intravenous Solutions Industry Opportunities and Challenges
  4. 2.4 Intravenous Solutions Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intravenous Solutions Revenue (2021-2026)
  2. 3.2 Global Top Players by Intravenous Solutions Sales (2021-2026)
  3. 3.3 Global Top Players by Intravenous Solutions Price (2021-2026)
  4. 3.4 Global Intravenous Solutions Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous Solutions Major Company Production Sites & Headquarters
  6. 3.6 Global Intravenous Solutions Company, Product Type & Application
  7. 3.7 Global Intravenous Solutions Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous Solutions Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous Solutions Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous Solutions Tier 1, Tier 2, and Tier 3
4 Intravenous Solutions Regional Status and Outlook
  1. 4.1 Global Intravenous Solutions Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intravenous Solutions Historic Market Size by Region
  3. 4.2.1 Global Intravenous Solutions Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intravenous Solutions Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intravenous Solutions Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intravenous Solutions Forecasted Market Size by Region
  7. 4.3.1 Global Intravenous Solutions Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intravenous Solutions Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intravenous Solutions Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intravenous Solutions by Application
  1. 5.1 Intravenous Solutions Market by Application
  2. 5.1.1 Basic IV Solutions
  3. 5.1.2 Nutrient Infusion Solution
  4. 5.1.3 Others
  5. 5.2 Global Intravenous Solutions Market Size by Application
  6. 5.2.1 Global Intravenous Solutions Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Intravenous Solutions Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Intravenous Solutions Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Intravenous Solutions Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Intravenous Solutions Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Intravenous Solutions Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Intravenous Solutions Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Intravenous Solutions Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Baxter
  2. 6.1.1 Baxter Company Information
  3. 6.1.2 Baxter Business Overview
  4. 6.1.3 Baxter Intravenous Solutions Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Baxter Intravenous Solutions Product Portfolio
  6. 6.1.5 Baxter Recent Developments
  7. 6.2 Kelun Group
  8. 6.2.1 Kelun Group Company Information
  9. 6.2.2 Kelun Group Business Overview
  10. 6.2.3 Kelun Group Intravenous Solutions Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Kelun Group Intravenous Solutions Product Portfolio
  12. 6.2.5 Kelun Group Recent Developments
  13. 6.3 Fresenius Kabi
  14. 6.3.1 Fresenius Kabi Company Information
  15. 6.3.2 Fresenius Kabi Business Overview
  16. 6.3.3 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fresenius Kabi Intravenous Solutions Product Portfolio
  18. 6.3.5 Fresenius Kabi Recent Developments
  19. 6.4 Otsuka
  20. 6.4.1 Otsuka Company Information
  21. 6.4.2 Otsuka Business Overview
  22. 6.4.3 Otsuka Intravenous Solutions Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Otsuka Intravenous Solutions Product Portfolio
  24. 6.4.5 Otsuka Recent Developments
  25. 6.5 ICU Medical
  26. 6.5.1 ICU Medical Company Information
  27. 6.5.2 ICU Medical Business Overview
  28. 6.5.3 ICU Medical Intravenous Solutions Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 ICU Medical Intravenous Solutions Product Portfolio
  30. 6.5.5 ICU Medical Recent Developments
  31. 6.6 Fresenius Kabi
  32. 6.6.1 Fresenius Kabi Company Information
  33. 6.6.2 Fresenius Kabi Business Overview
  34. 6.6.3 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fresenius Kabi Intravenous Solutions Product Portfolio
  36. 6.6.5 Fresenius Kabi Recent Developments
  37. 6.7 JW Life Science
  38. 6.7.1 JW Life Science Company Information
  39. 6.7.2 JW Life Science Business Overview
  40. 6.7.3 JW Life Science Intravenous Solutions Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 JW Life Science Intravenous Solutions Product Portfolio
  42. 6.7.5 JW Life Science Recent Developments
  43. 6.8 B. Braun Melsungen
  44. 6.8.1 B. Braun Melsungen Company Information
  45. 6.8.2 B. Braun Melsungen Business Overview
  46. 6.8.3 B. Braun Melsungen Intravenous Solutions Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 B. Braun Melsungen Intravenous Solutions Product Portfolio
  48. 6.8.5 B. Braun Melsungen Recent Developments
7 North America by Country
  1. 7.1 North America Intravenous Solutions Sales by Country
  2. 7.1.1 North America Intravenous Solutions Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intravenous Solutions Sales by Country (2021-2026)
  4. 7.1.3 North America Intravenous Solutions Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intravenous Solutions Market Size by Country
  6. 7.2.1 North America Intravenous Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intravenous Solutions Market Size by Country (2021-2026)
  8. 7.2.3 North America Intravenous Solutions Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intravenous Solutions Sales by Country
  2. 8.1.1 Europe Intravenous Solutions Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intravenous Solutions Sales by Country (2021-2026)
  4. 8.1.3 Europe Intravenous Solutions Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intravenous Solutions Market Size by Country
  6. 8.2.1 Europe Intravenous Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intravenous Solutions Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intravenous Solutions Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intravenous Solutions Sales by Country
  2. 9.1.1 Asia-Pacific Intravenous Solutions Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intravenous Solutions Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intravenous Solutions Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intravenous Solutions Market Size by Country
  6. 9.2.1 Asia-Pacific Intravenous Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intravenous Solutions Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intravenous Solutions Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intravenous Solutions Sales by Country
  2. 10.1.1 South America Intravenous Solutions Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intravenous Solutions Sales by Country (2021-2026)
  4. 10.1.3 South America Intravenous Solutions Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intravenous Solutions Market Size by Country
  6. 10.2.1 South America Intravenous Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intravenous Solutions Market Size by Country (2021-2026)
  8. 10.2.3 South America Intravenous Solutions Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intravenous Solutions Sales by Country
  2. 11.1.1 Middle East and Africa Intravenous Solutions Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intravenous Solutions Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intravenous Solutions Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intravenous Solutions Market Size by Country
  6. 11.2.1 Middle East and Africa Intravenous Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intravenous Solutions Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intravenous Solutions Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intravenous Solutions Value Chain Analysis
  2. 12.1.1 Intravenous Solutions Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intravenous Solutions Production Mode & Process
  7. 12.2 Intravenous Solutions Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intravenous Solutions Distributors
  10. 12.2.3 Intravenous Solutions Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst